3rd Circ. Won't Give Fresenius Another Look At Drug Claim
A Third Circuit panel on Tuesday refused to revisit its finding that Fresenius Kabi USA LLC gave up its tortious interference claim against Par Pharmaceuticals for allegedly delaying Fresenius from marketing...To view the full article, register now.
Already a subscriber? Click here to view full article